Insider · CIK 0001314595
Dennis Podlesak
Files at SNDX (Syndax Pharmaceuticals Inc). First filing Aug 18, 2025, latest Aug 18, 2025.
Dennis Podlesak files SEC Form 4 as director at SNDX (Syndax Pharmaceuticals Inc). Since Aug 18, 2025, Dennis Podlesak has reported 0 open-market buys worth $0 and 1 open-market sell worth $875k, the latest filed on Aug 18, 2025.
A track record needs three past buys with six months of prices behind them; Dennis Podlesak has 0, so none is measured yet.
The newest scored trade: sold $875k of SNDX on Aug 14, 2025, filed Aug 18, 2025, scored 13 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SNDX: Syndax Pharmaceuticals Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | Syndax Pharmaceuticals Inc | $875k 57,600 shares | -27% | +69% from low-32% from high |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Common Stock | +48,000 | $0.00 | $0 | 239,763 | Feb 6, 2026 |
| Aug 14, 2025 | SNDX Syndax Pharmaceuticals Inc | MOption exercise Common Stock10b5-1 | +19,200 | $7.20 | $138k | 210,963 | Aug 18, 2025 |
| Aug 14, 2025 | SNDX Syndax Pharmaceuticals Inc | SOpen-market sale Common Stock10b5-1 | -19,200 | $14.19 | $273k | 191,763 | Aug 18, 2025 |
| Aug 15, 2025 | SNDX Syndax Pharmaceuticals Inc | MOption exercise Common Stock10b5-1 | +19,200 | $7.20 | $138k | 210,963 | Aug 18, 2025 |
| Aug 15, 2025 | SNDX Syndax Pharmaceuticals Inc | SOpen-market sale Common Stock10b5-1 | -19,200 | $15.54 | $298k | 191,763 | Aug 18, 2025 |
| Aug 18, 2025 | SNDX Syndax Pharmaceuticals Inc | MOption exercise Common Stock10b5-1 | +19,200 | $7.20 | $138k | 210,963 | Aug 18, 2025 |
| Aug 18, 2025 | SNDX Syndax Pharmaceuticals Inc | SOpen-market sale Common Stock10b5-1 | -19,200 | $15.84 | $304k | 191,763 | Aug 18, 2025 |
| Aug 14, 2025 | SNDX Syndax Pharmaceuticals Inc | MOption exercise Stock Options (Right to buy)derivative10b5-1 | -19,200 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 15, 2025 | SNDX Syndax Pharmaceuticals Inc | MOption exercise Stock Options (Right to buy)derivative10b5-1 | -14,400 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 15, 2025 | SNDX Syndax Pharmaceuticals Inc | MOption exercise Stock Options (Right to buy)derivative10b5-1 | -4,800 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 18, 2025 | SNDX Syndax Pharmaceuticals Inc | MOption exercise Stock Options (Right to buy)derivative10b5-1 | -19,200 | $0.00 | $0 | 0 | Aug 18, 2025 |
Questions about Dennis Podlesak
Answered from the filings on this page, as of the latest one.
Is Dennis Podlesak buying or selling?
Not in the last 12 months. Dennis Podlesak's latest open-market trade on SEC Form 4 was sold $875k of SNDX on Aug 14, 2025.
How did Dennis Podlesak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dennis Podlesak has 0.
Where does Dennis Podlesak file Form 4?
Dennis Podlesak has filed Form 4 at SNDX (Syndax Pharmaceuticals Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.